Brad Perkins

Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.

GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ.

Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.

Asteres, Inc. develops secure self-service kiosks for the storage and delivery of prescriptions and consumer products. Its product script center, the prescription pickup kiosk for retail, healthcare and military pharmacies that allows patients to pick up and pay for their prescriptions and other items even when the pharmacy is closed. The company was founded by Linda J. Pinney and John A. Beane in 2003 and is headquartered in San Diego, CA.

Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA.

NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.

Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA.

Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ.

Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA.

SRC Holdings Corp. provides remanufacturing of engines, engine parts. The company provides remanufacturing services to automobiles, commercial trucks, agricultural equipment, and construction vehicles. The company was founded by Jack P. Stack in 1983 and is headquartered in Springfield, MO.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

Part of Investec Plc, IndexIT Partnership is a British company that provides information technology consulting services. The company is based in Oxford, UK. The company was founded by David Robert Norwood. IndexIT Partnership was acquired by Beeson Gregory Group Plc on February 04, 2000.

Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California.

Part of Tissue Regenix Group Plc, Oxray Ltd. develops software for molecular structure determination. The company is based in Oxford, UK. The British company was founded by Stephen Davies John Davies. Oxray was acquired by Oxeco Plc on June 15, 2007 for $23.62 million.

Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom.

Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies.

Orthox Ltd. develops tissue regenerative implants. The firm?s products include FibroFix Meniscus and FibroFix Cartilage. The company was founded by Nicholas James Vavasour Skaer and Oliver Kessler in 2008 and is headquartered in Abingdon, the United Kingdom.

Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom.

Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom.

Oxford Electromagnetic Solutions Ltd. designs and develops cloud-based, end-to-end smart asset management system. The firm offers OXEMS tag, Application, detector and database products. The company was founded in 2010 and is headquartered in Oxford, the United Kingdom.

Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom.

Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London.

OrthoSon Ltd. engages in the development of novel medical device for the treatment of chronic low back pain. The company was founded by Constantin Coussios and is headquartered in Oxford, the United Kingdom.

Orthox Holdings Ltd. is a British biotechnology company founded in 2014. The private company is based in Abingdon, UK and engages in research and experimental development of biotechnology.

Ecomine Technologies Corp. is a Canadian mining technology company. The private company was founded by Robert Crandall Greene, Robert Crandall Greene.

Energy Revolution Ventures is a venture capital firm founded in 2021. Energy Revolution Ventures is headquartered in London, United Kingdom.

ITsavvy LLC provides computer hardware, software and related installation and support services to businesses. Its services include virtual demo lab, configuration and depot lab, architecture, implementation, problem remediation, hardware repair services, asset management and warranty services. The company was founded by Michael A. Theriault and Christopher Kurpeikis in April 2004 and is headquartered in Addison, IL.

Part of Summit Therapeutics, Inc., MuOx Ltd. is a British company that develops utrophin modulators and biological screening equipment. The company is based in Abingdon, UK. The company was founded in 2012 by Stephen Davies John Davies. MuOx was acquired by Summit Therapeutics Ltd. on November 25, 2013 for $5.27 million.